Unlike pharmas, which won a seat at the table with substantial concessions, device makers didn't play ball with the White House and Senate Finance Committee Democrats when they were negotiating the legislation in 2009. The excise tax, which will chomp up 2.3% of their revenues (regardless, device makers note, of whether or not they make a profit) starting next year, was their punishment.As this administration has shown in the past, playing ball can be rewarded. Unfortunately, it does require you to give up your principles...
Now one of the biggest device manufacturers, Stryker Corp., has tied plans to slash 5% of its global workforce – in part by shuttering two New York plants – to the tax. Stryker said it will close its West Seneca, New York plant in September, impacting 11 employees, and its Orchard Park, New York facility in December, eliminating 96 jobs there. The firm said it would provide laid-off employees with severance packages, counseling and job placement services. Stryker acquired the plants in 2010 with its purchase of Gaymar Industries, which specialized in support surface and pressure ulcer management products as well as temperature management.
Stryker said last November that it would eliminate 5% of its global workforce as part of an effort to realize $100 million in annual productivity gains to offset the hit when the excise tax takes effect in 2013.
Thursday, November 15, 2012
Obamacare leaves its mark on medical device manufacturers: